Analyst
BMO Capital Markets
Equibles does not estimate personal net worth.
Evan Sigerman is recorded as Analyst at BMO Capital Markets. Evan Sigerman has spoken on 2 earnings calls across 2 companies, most recently for Pfizer Inc on August 4, 2026. Those appearances were for Pfizer Inc (PFE) and Merck & Co., Inc. (MRK). The companies whose calls Evan Sigerman spoke on are classified in the Healthcare sector.
“Before I ask my question, I want to express my gratitude and congratulations to Dave. You'll be missed. Cecile, we're looking forward to working with you. So ahead of the MEVPRO-1 data, Chris, I'd love it if you could help us define how you view success.”
“Kyle, thank you so much for taking my question. Kind of a key theme from this call talked about the $70 billion potential opportunity that you talked about over the next wave of products.”
BMO Capital Markets
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
PFE
Drug Manufacturers - General · Healthcare
